207 related articles for article (PubMed ID: 29061289)
1. Importance of neoadjuvant chemotherapy in olfactory neuroblastoma treatment: Series report and literature review.
Bartel R; Gonzalez-Compta X; Cisa E; Cruellas F; Torres A; Rovira A; Manos M
Acta Otorrinolaringol Esp (Engl Ed); 2018; 69(4):208-213. PubMed ID: 29061289
[TBL] [Abstract][Full Text] [Related]
2. Outcomes and Quality-of-Life Measures after Endoscopic Endonasal Resection of Kadish Stage C Olfactory Neuroblastomas.
Sun Y; Huang Q; Cui S; Wang M; Zhang N; Zhang S; Yang B; Qiu E; Huang Z; Zhou B
World Neurosurg; 2021 Jul; 151():e58-e67. PubMed ID: 33798777
[TBL] [Abstract][Full Text] [Related]
3. The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: the University of Virginia experience.
Polin RS; Sheehan JP; Chenelle AG; Munoz E; Larner J; Phillips CD; Cantrell RW; Laws ER; Newman SA; Levine PA; Jane JA
Neurosurgery; 1998 May; 42(5):1029-37. PubMed ID: 9588547
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic Endonasal Management of Olfactory Neuroblastoma: A Retrospective Analysis of 10 Patients with Quality-of-Life Measures.
Manthuruthil C; Lewis J; McLean C; Batra PS; Barnett SL
World Neurosurg; 2016 Jun; 90():1-5. PubMed ID: 26899467
[TBL] [Abstract][Full Text] [Related]
5. Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma.
Miller KC; Marinelli JP; Van Gompel JJ; Link MJ; Janus JR; Foote RL; Price KA; Garcia J; Rivera M; Chintakuntlawar AV
Head Neck; 2019 May; 41(5):1335-1341. PubMed ID: 30536472
[TBL] [Abstract][Full Text] [Related]
6. [Olfactory neuroblastoma: own experiences].
Jarzabski A; Kawecki A; Jagielska B
Otolaryngol Pol; 2000; 54 Suppl 31():94-7. PubMed ID: 10974854
[TBL] [Abstract][Full Text] [Related]
7. [Esthesioneuroblastoma: A single institution's experience and general literature review].
Lapierre A; Selmaji I; Samlali H; Brahmi T; Yossi S
Cancer Radiother; 2016 Dec; 20(8):783-789. PubMed ID: 27449859
[TBL] [Abstract][Full Text] [Related]
8. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb.
Mays AC; Bell D; Ferrarotto R; Phan J; Roberts D; Fuller CD; Frank SJ; Raza SM; Kupferman ME; DeMonte F; Hanna EY; Su SY
Laryngoscope; 2018 Jun; 128(6):1274-1280. PubMed ID: 29226334
[TBL] [Abstract][Full Text] [Related]
9. [The results of combined treatment patients with olfactory neuroblastoma in material of Cancer Center in Warsaw].
Jarząbski A; Kiprian D; Szutkowski Z; Kawecki A; Michalski W
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):93-7. PubMed ID: 22000257
[TBL] [Abstract][Full Text] [Related]
10. Extensive tumor calcification in response to pre-operative reductive chemotherapy in pediatric esthesioneuroblastoma: a case report.
McDowell MM; Roy S; Goldschmidt E; Gardner PA; Tyler-Kabara E; Snyderman CH
Childs Nerv Syst; 2020 Sep; 36(9):2099-2102. PubMed ID: 32100079
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
12. Treatment and outcome in 12 cases of olfactory neuroblastoma at Mexico´s National Cancer Institute: A retrospective clinical analysis and literature review.
Navarro-Fernández JO; Serrato-Avila JL; Hernández-Varela M; Tejada-Pineda MF; Hernández-Reséndiz RE; Monroy-Sosa A; Cacho-Díaz B; Herrera-Gómez Á; Reyes-Soto G
Cir Cir; 2020; 88(4):453-460. PubMed ID: 32567594
[TBL] [Abstract][Full Text] [Related]
13. Esthesioneuroblastoma: continued follow-up of a single institution's experience.
Loy AH; Reibel JF; Read PW; Thomas CY; Newman SA; Jane JA; Levine PA
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):134-8. PubMed ID: 16490869
[TBL] [Abstract][Full Text] [Related]
14. Ectopic Primary Olfactory Neuroblastoma: Case Series and Literature Review.
Turri-Zanoni M; Gravante G; Dalfino G; Antognoni P; Locatelli D; Battaglia P; Castelnuovo P
World Neurosurg; 2022 Feb; 158():e645-e653. PubMed ID: 34785363
[TBL] [Abstract][Full Text] [Related]
15. Olfactory neuroblastoma: 14-year experience at an Australian tertiary centre and the role for longer-term surveillance.
Schmidt C; Potter N; Porceddu S; Panizza B
J Laryngol Otol; 2017 Jul; 131(S2):S29-S34. PubMed ID: 27917732
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Kim DW; Jo YH; Kim JH; Wu HG; Rhee CS; Lee CH; Kim TY; Heo DS; Bang YJ; Kim NK
Cancer; 2004 Nov; 101(10):2257-60. PubMed ID: 15484215
[TBL] [Abstract][Full Text] [Related]
17. Esthesioneuroblastoma: irradiation alone and surgery alone are not enough.
Gruber G; Laedrach K; Baumert B; Caversaccio M; Raveh J; Greiner R
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):486-91. PubMed ID: 12243826
[TBL] [Abstract][Full Text] [Related]
18. Patient characteristics of olfactory neuroblastoma: experience from a tertiary cancer centre 2000-2016 covering Eastern Denmark.
Gram SB; Grønhøj C; Mann H; Jakobsen KK; Kiss K; Bilde A; von Buchwald C
APMIS; 2018 Aug; 126(8):663-666. PubMed ID: 30168622
[TBL] [Abstract][Full Text] [Related]
19. Esthesioneuroblastoma: 25-year experience at a single institution.
Zafereo ME; Fakhri S; Prayson R; Batra PS; Lee J; Lanza DC; Citardi MJ
Otolaryngol Head Neck Surg; 2008 Apr; 138(4):452-8. PubMed ID: 18359353
[TBL] [Abstract][Full Text] [Related]
20. Esthesioneuroblastoma chemotherapy and radiotherapy for extensive disease: a case report.
Gupta S; Husain N; Sundar S
World J Surg Oncol; 2011 Oct; 9():118. PubMed ID: 21974776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
